These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7235194)

  • 1. Spontaneously acquired Factor IX inhibitors in childhood.
    Berman BW; McIntosh S; Clyne LP; Goldberg B; Lobel J; Komp DM
    Am J Pediatr Hematol Oncol; 1981; 3(1):77-81. PubMed ID: 7235194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study Group.
    White GC; Shapiro AD; Kurczynski EM; Kim HC; Bergman GE
    Thromb Haemost; 1995 May; 73(5):779-84. PubMed ID: 7482403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors in young boys with haemophilia.
    Lusher JM
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):457-68. PubMed ID: 11030045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired inhibitor against factor IX in a child: successful treatment with high-dose immunoglobulin and dexamethasone.
    Mazzucconi MG; Peraino M; Bizzoni L; Bernasconi S; Luciani M; Rossi GD
    Haemophilia; 1999 Mar; 5(2):132-4. PubMed ID: 10215963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.
    Makris M; Greaves M; Phillips WS; Kitchen S; Rosendaal FR; Preston EF
    Thromb Haemost; 1997 Mar; 77(3):477-80. PubMed ID: 9065997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience in intensive care of acute massive bleeding in children].
    Marochkov AV; Zagorskiĭ II
    Anesteziol Reanimatol; 1996; (6):63-5. PubMed ID: 9045589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic findings and management of dengue patients with upper gastrointestinal bleeding.
    Chiu YC; Wu KL; Kuo CH; Hu TH; Chou YP; Chuah SK; Kuo CM; Kee KM; Changchien CS; Liu JW; Chiu KW
    Am J Trop Med Hyg; 2005 Aug; 73(2):441-4. PubMed ID: 16103618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion requirements in patients with dengue hemorrhagic fever.
    Chuansumrit A; Phimolthares V; Tardtong P; Tapaneya-Olarn C; Tapaneya-Olarn W; Kowsathit P; Chantarojsiri T
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):10-4. PubMed ID: 11023057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma-derived FVIII or FIX concentrate: results from the French haemophilia cohort.
    Gaboulaud V; Parquet A; Tahiri C; Claeyssens S; Potard V; Faradji A; Peynet J; Costagliola D;
    Br J Haematol; 2002 Feb; 116(2):383-9. PubMed ID: 11841442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemorrhagic tonsillitis.
    Levy S; Brodsky L; Stanievich J
    Laryngoscope; 1989 Jan; 99(1):15-8. PubMed ID: 2909817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
    Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
    Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of patients with factor VIII and IX inhibitors.
    Nilsson IM; Berntorp E; Freiburghaus C
    Thromb Haemost; 1993 Jul; 70(1):56-9. PubMed ID: 8236114
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of uncontrollable, life-threatening hemorrhage].
    Stensballe J; Lethagen S; Johansson PI
    Ugeskr Laeger; 2005 Jun; 167(25-31):2789-90. PubMed ID: 16014269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneously acquired factor IX inhibitor in a nonhemophiliac child.
    Miller K; Neely JE; Krivit W; Edson JR
    J Pediatr; 1978 Aug; 93(2):232-4. PubMed ID: 671155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia A.
    Pejsa V; Grgurević I; Kusec R; Gaćina P
    Croat Med J; 2004 Apr; 45(2):213-6. PubMed ID: 15103761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors.
    de Raucourt E; Barbier C; Sinda P; Dib M; Peltier JY; Ternisien C
    Am J Hematol; 2003 Nov; 74(3):187-90. PubMed ID: 14587047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.